entity

lead

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about lead: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11Connections
4Hypotheses
6Analyses
11Outgoing
0Incoming
0Experiments
7Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Gilead Sciences

company · 2053 words

Outgoing (11)

TargetRelationTypeStr
reactive oxygen species productionpromotesprocess0.95
neurodegenerationcausesprocess0.95
oxidative stresspromotesprocess0.90
NFE2L2promotesgene0.90
APPupregulatesprotein0.88

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Age-Dependent TREM2 Signaling Disrupts Astrocyte-Microglia C 0.649 neurodegeneration Gene expression changes in aging mouse b
SASP-Secreted MMP-9 from Senescent Microglia Disrupts TDP-43 0.511 als What are the mechanisms by which microgl
Patients with OSA or high nocturnal arousal burden may requi 0.370 neurodegeneration -
SASP-Secreted MMP-9 from Senescent Microglia Disrupts Nuclea 0.361 als What are the mechanisms by which microgl

Mentioning Analyses (6)

Scientific analyses that reference this entity

Quantitative proteomics of the aging synapse: protein turnover and aggregation i

proteomics | 2026-04-16 | 19 hypotheses Top: 0.591

How do ALS-associated OPTN mutations mechanistically disrupt Rab8a binding and c

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.521

What is the molecular mechanism by which oligodendroglial MCT1 disruption causes

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.698

What upstream mechanisms cause TDP-43 to trigger mPTP opening and can this be th

neurodegeneration | 2026-04-08 | 5 hypotheses Top: 0.693

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

neurodegeneration | 2026-04-07 | 3 hypotheses Top: 0.595

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (4)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Loss of Nuclear TDP-43 Impairs Lipid Metabolism in Microglia-Like Cells. [PMID:41000837] Unknown bioRxiv 2025 0
Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopat [PMID:34412701] Unknown Acta Neuropathol Commun 2021 0
Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP- [PMID:30458231] Unknown Neurobiology of disease 2019 0
TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synaps [PMID:28669544] Unknown Neuron 2017 0

Debates (7)

Multi-agent debates referencing this entity

While the study establishes that trehalose-induced lysosomal permeabilization ac

closed · Rounds: 4 · Score: 0.73 · 2026-04-21

TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leadi

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

While the study demonstrates TDP-43 triggers mPTP-mediated mtDNA release, the mo

closed · Rounds: 4 · Score: 0.77 · 2026-04-21

How does synaptic protein turnover change with age and neurodegeneration, and wh

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

The authors evaluate several ALS-associated mutations in OPTN's leucine-zipper d

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

The study shows that MCT1 disruption leads to axon degeneration and neuron death

closed · Rounds: 4 · Score: 0.78 · 2026-04-14

The study shows that MCT1 disruption leads to axon degeneration and neuron death

closed · Rounds: 4 · Score: 0.82 · 2026-04-13

Related Research

Hypotheses and analyses mentioning lead in their description or question text

No additional research found